American Medical Association (AMA)

The following notices and terms apply to CPT® content licensed from the American Medical Association (“AMA”) and made available through Nabla’s products. CPT® content is provided pursuant to Nabla’s licensing agreement with the AMA. Use of CPT® content is subject to the terms below.

1. Copyright Notice

Licensed Content is copyrighted by the American Medical Association and CPT is a registered trademark of the AMA.

2. License Grant

Licensee, as a party to a license agreement with the AMA, is authorized to grant End User a limited, non-exclusive, non-transferable, non-sublicensable license for End User to use Licensed Content in Licensee’s Licensed Product(s), for the sole purpose of internal use by End User within the Territory.

Upon termination or expiration of the Agreement between Licensee and AMA, Licensee shall notify End User. End User shall continue to have the right to use Licensed Content in the Licensee’s Licensed Product(s) for the remainder of year of the then-current annual release (e.g., through the end of the applicable calendar year) (“End User Tail Period”). End User’s continued use of the Licensed Content during the End User Tail Period is subject to End User’s continued compliance with all its obligations under these terms. Upon the expiration of the End User Tail Period, the sublicense granted under these terms shall automatically terminate.

3. Updates

The provision of updated Licensed Content in the Licensed Product(s) is dependent on a continuing contractual relationship between Licensee and the AMA.

4. Restrictions

End User is prohibited from making Licensed Content publicly available; creating derivative works (including translating) of the Licensed Content; and transferring, selling, leasing, licensing, or otherwise making available the Licensed Content, or a copy or portion of Licensed Content, to any unauthorized party, including a subsidiary, affiliate, or other legal entity, however designated, for any purpose whatsoever except as expressly permitted in this Agreement.

5. Disclaimer

End User expressly acknowledges and agrees to the extent permitted by applicable law, use of the Licensed Content is at End User’s sole risk and the Licensed Content is provided “as is” without warranty of any kind.

The AMA does not directly or indirectly practice medicine or dispense medical services. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The Licensed Content does not replace the AMA’s Current Procedural Terminology book or other appropriate coding authority. The coding information contained in the Licensed Content should be used only as a guide.

6. Reporting Requirements

End User is required to keep records and submit reports including information necessary for the calculation of royalties payable to the AMA by the Licensee, of the same type as required of Licensee under this Agreement. End User consents to the release of such information to the AMA.

This agreement does not grant the Federal Government a direct license to use CPT based on FAR 52.227-14 (Data Rights — General) and DFARS 252.227-7015 (Technical Data — Commercial Items).

End User further agrees to provide, without delay, additional information that the AMA (as a third-party beneficiary) may reasonably request, to verify the information. Nothing herein shall require End User to submit or release information that would cause End User to be in violation of applicable federal or state privacy laws.

7. U.S. Government End Users

CPT is commercial technical data, which was developed exclusively at private expense by the American Medical Association (AMA), 330 North Wabash Avenue, Chicago, Illinois 60611.

8. Authorized Users

End User must ensure that anyone with authorized access to the Licensed Product(s) will comply with the provisions of the End User Agreement.

9. Third-Party Beneficiary

AMA shall be named as a third-party beneficiary of the End User Agreement.

10. Consent

End User expressly consents to the release of its name to the AMA.

Third-Party Clinical Decision Support Services

Certain Third-Party Features allow you to submit clinical queries to, or receive information from, an identified third-party clinical decision support service (“CDS Provider”). By using a CDS Provider feature, you direct and authorize Nabla to append to your query a subset of patient context from the relevant Nabla encounter that Nabla has de-identified in accordance with HIPAA. You are responsible for the content of queries and other information you submit.

Nabla will identify the applicable CDS Provider before transmission. The CDS Provider’s handling of information is governed by its applicable terms, privacy policy, and any agreement between the CDS Provider and you or your organization, unless Nabla expressly agrees otherwise in writing.

For additional information about Nabla’s data practices, please review our Terms of Service and Privacy Policy. After transmission, each CDS Provider may use the query, de-identified patient context, and related activity as described in the provider-specific notice below and the CDS Provider’s applicable terms and privacy policy.

Use of each CDS Provider is optional.

1. DynaMed

When you submit a DynaMed query, Nabla automatically sends the query and de-identified patient context to DynaMed through its clinical decision support service. Do not include PHI in your query.

Disclaimer

Dyna AI responses are for educational purposes only and should not be solely relied upon for medical practice. The presentation of a response does not imply any specific ranking by importance or probability, and a response may not include all possibly relevant material.

Interpretation and application are subject to the judgment of a healthcare professional. Dyna AI responses are not intended to serve as recommendations for individual patients. Do not enter Protected Health Information, as defined by HIPAA (”PHI”).

2. OpenEvidence

When you submit an OpenEvidence query, Nabla automatically sends the query and de-identified patient context to OpenEvidence. OpenEvidence opens on its own platform and may associate the query and related activity with your OpenEvidence account.

OpenEvidence’s handling of information is governed by its applicable policies and any agreement between OpenEvidence and you or your organization:

• Terms of Use
• Privacy Policy
• Business Associate Agreement, where applicable

OpenEvidence’s Privacy Policy states that it may use platform activity for service improvement, personalization, advertising, and analytics. It may use de-identified or aggregated information for reports, statistics, and other analyses shared with partners or the public. It may also retain anonymized information indefinitely for research, statistical, or business purposes.

This feature is intended for use only with de-identified patient information. Do not include PHI in your query or otherwise submit PHI through this feature. If you independently submit PHI directly to OpenEvidence after leaving Nabla, that submission is governed by OpenEvidence’s applicable terms and Business Associate Agreement. Nabla does not control that direct submission.

‍